Ispire Technology Inc. shares rise 1.04% premarket after Inspire Medical Systems, Inc. reported Q2 earnings and lowered full-year revenue guidance.

Ispire Technology Inc. rose 1.04% in premarket trading, with the company facing an investigation by The Schall Law Firm for potential securities law violations. The investigation focuses on whether Inspire Medical Systems, Inc. issued false and/or misleading statements and/or failed to disclose information pertinent to investors, following the company's Q2 earnings report on August 4, 2025, which lowered its full-year revenue guidance and disclosed delays in the rollout of its 'Inspire V' system.